✦ LIBER ✦

Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C

✍ Scribed by Hans L. Tillmann; Keyur Patel; John G. McHutchison

Book ID: 107538459
Publisher: Springer
Year: 2009
Tongue: English
Weight: 374 KB
Volume: 11
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-009-0002-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thrombopoietic Agents for the Treatment

Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children

✍ Ramaswamy, Kavitha; Hsieh, Loan; Leven, Emily; Thompson, Michaela V.; Nugent, Di 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 927 KB

Re-evaluating the use of growth factors

Re-evaluating the use of growth factors as adjuvant treatment of chronic hepatitis C

✍ Howard J. Worman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

The role of alcoholic and metabolic co-f

The role of alcoholic and metabolic co-factors in chronic hepatitis C

✍ Giovanni G Tarantino; Paolo P Conca; Paolo P Sorrentino; Paola P Ragucci; Manuel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Prospectives on the treatment of chronic

Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents

✍ Milton G. Mutchnick; Murray N. Ehrinpreis; Joseph L. Kinzie; Rene R. Peleman 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 854 KB

1171 ROLE OF IRON METABOLISM IN CHRONIC

1171 ROLE OF IRON METABOLISM IN CHRONIC HEPATITIS C TREATMENT

✍ Nakamuta, M.; Kohjima, M.; Shimonaka, Y.; Yada, R.; Taketomi, A.; Gotoh, K.; Yos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Predictors of treatment in patients with

Predictors of treatment in patients with chronic hepatitis C infection—Role of patient versus nonpatient factors

✍ Fasiha Kanwal; Tuyen Hoang; Brennan M.R. Spiegel; Seth Eisen; Jason A. Dominitz; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Treatment with interferon and ribavirin is effective in patients with chronic infection with hepatitis C virus (HCV). Previous data indicate that treatment rates are suboptimal. We sought to identify patient and provider-level predictors of treatment receipt in HCV by conducting a retrospective coho